Evidence map›Paper›PMID 40700604›Full record

SynthesisThe oncologist2025

Changes in quality of life throughout the illness trajectory of older adults with cancer: a systematic review.

Chelsea Vinckier, Kim de Nooijer, Tinne Smets, Helena Du Cheyne, Lore Decoster, Lieve Van den Block

Abstract readSystematic Review
In one paragraph

Synthesis in The oncologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chelsea VinckierEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium & Ghent University, Ghent 9000, Belgium.ORCID 0009-0004-9258-4978
Kim de NooijerEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium & Ghent University, Ghent 9000, Belgium.
Tinne SmetsEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium & Ghent University, Ghent 9000, Belgium.
Helena Du CheyneEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium & Ghent University, Ghent 9000, Belgium.
Lore DecosterDepartment of Medical Oncology, University Hospital Brussel (UZ Brussel), Translational Oncology Research Center (TORC) team laboratory for medical and molecular oncology, Vrije Universiteit Brussel (VUB), Brussels 1090, Belgium.
Lieve Van den BlockEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB), Brussels, Belgium & Ghent University, Ghent 9000, Belgium.

Funding

Cancer and Their Family CaregiversEU NAVIGATEEuropean Health and Digital Executive AgencyEuropean Union 101057361International Pragmatic Randomized Controlled TrialNavCare-EU Intervention for Older PeopleResearch Foundation Flanders-Fonds Wetenschappelijk Onderzoek 12AEO24N
6 · The paper itself

Abstract

backgroundOlder adults with cancer often experience frailty and comorbidities, potentially impacting their quality of life. Knowledge on quality-of-life changes throughout the cancer trajectory is important to set feasible expectations in interventions or trials.

aimThis systematic review synthesizes existing knowledge on quality-of-life changes in older adults with cancer throughout their illness trajectory and explores potential individual, relational, community, and societal factors associated with these changes.

methodWe systematically searched PubMed, Embase, and PsycINFO. We synthesized characteristics and outcomes of all studies reporting on quality-of-life or well-being changes in people aged 65+ with cancer. We used Bronfenbrenner's Social Ecological Model to categorize associated factors. We followed PRISMA guidelines and registered in PROSPERO (CRD42024566815).

resultsWe included 22 studies. Studies varied in characteristics of the cohorts and timing of the measurements and were often lacking clear quality-of-life conceptualizations. All studies used a quantitative design, except 1 mixed-methods study. Eight of 9 studies with follow-up moments of 12 months or more reported stable quality-of-life scores. All 3 studies examining the last year of life found quality-of-life declines. Five other studies reported a decline during treatment; in 4 studies followed by an increase. Comorbidities, older age, and mobility problems were most frequently associated with declining quality of life. Relational, community, and societal level factors were rarely studied.

conclusionDespite the methodological heterogeneity between studies, we identified trends in quality-of-life changes across the illness trajectories of older adults with cancer, particularly declining trends during treatment and end-of-life periods and stable trends in long-term follow-up.

Indexed as

NeoplasmsQuality of LifeAgedAged, 80 and overFemaleHumansMaleagedlongitudinal studiesneoplasmsquality of lifesystematic reviewtrends

Identifiers

PMID40700604
PMCPMC12445657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.